Auro Labs.

35
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE292C01011
  • NSEID:
  • BSEID: 530233
INR
249.85
24.55 (10.9%)
BSENSE

Feb 03

BSE+NSE Vol: 7.77 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -63.83% vs 1.40% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -68.10% vs 142.90% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 47.13% vs -9.64% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -76.40% vs 219.09% in Mar 2024

Compare Profit and Loss Results of Auro Labs.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
19.00
2.00
17.00
850.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
19.00
2.00
17.00
850.00%
Expenditure (Ex Depriciation)
Stock Adjustments
4.00
-9.00
13.00
144.44%
Raw Materials Consumed
5.00
11.00
-6.00
-54.55%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
2.00
3.00
-1.00
-33.33%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
0.00
1.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
2.00
-1.00
-50.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
15.00
9.00
6.00
66.67%
Operating Profit (PBDIT) excl Other Income
3.00
-7.00
10.00
142.86%
Other Income
0.00
1.00
-1.00
-100.00%
Operating Profit (PBDIT)
4.00
-6.00
10.00
166.67%
Interest
1.00
2.00
-1.00
-50.00%
Profit before Depriciation and Tax
2.00
-8.00
10.00
125.00%
Depreciation
1.00
0.00
1.00
0%
Profit Before Taxation & Exceptional Items
1.00
-8.00
9.00
112.50%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
1.00
-8.00
9.00
112.50%
Provision for Tax
0.00
-1.00
1.00
100.00%
Profit After Tax
1.00
-7.00
8.00
114.29%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
35.00
-14.00
49.00
350.00%
Profit Available for appropriations
36.00
-22.00
58.00
263.64%
Appropriations
36.00
-22.00
58.00
263.64%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
2.95
-2.06
5.01
243.20%
Profit And Loss - Net Sales
Net Sales 19.40 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -63.83% vs 1.40% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.40 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -68.10% vs 142.90% in Mar 2024

Profit And Loss - Interest
Interest 1.08 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 47.13% vs -9.64% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 1.84 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -76.40% vs 219.09% in Mar 2024